Cargando…
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
Several studies reported that metformin, the most widely used drug for type 2 diabetes, might affect cancer aggressiveness. The biguanide seems to directly impair cancer energy asset, with the consequent phosphorylation of AMP-activated protein kinase (AMPK) inhibiting cell proliferation and tumor g...
Autores principales: | Marini, Cecilia, Cossu, Vanessa, Bauckneht, Matteo, Lanfranchi, Francesco, Raffa, Stefano, Orengo, Anna Maria, Ravera, Silvia, Bruno, Silvia, Sambuceti, Gianmario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392176/ https://www.ncbi.nlm.nih.gov/pubmed/34439897 http://dx.doi.org/10.3390/biom11081231 |
Ejemplares similares
-
18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress
por: Miceli, Alberto, et al.
Publicado: (2020) -
Two high-rate pentose-phosphate pathways in cancer cells
por: Cossu, Vanessa, et al.
Publicado: (2020) -
The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes
por: Cossu, Vanessa, et al.
Publicado: (2020) -
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells
por: Scussolini, Mara, et al.
Publicado: (2019) -
Spleen Perfusion as an Index of Gender Impact on Sympathetic Nervous System Response to Exercise
por: Lanfranchi, Francesco, et al.
Publicado: (2021)